Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2–10 ng/ml M Ferro, D Bruzzese, S Perdona, A Marino, C Mazzarella, G Perruolo, ... PloS one 8 (7), e67687, 2013 | 133 | 2013 |
Biomarkers in localized prostate cancer M Ferro, C Buonerba, D Terracciano, G Lucarelli, V Cosimato, D Bottero, ... Future Oncology 12 (3), 399-411, 2016 | 68 | 2016 |
Improving the Prediction of Pathologic Outcomes in Patients Undergoing Radical Prostatectomy: The Value of Prostate Cancer Antigen 3 (PCA3), Prostate Health Index (Phi) and … TD Ferro M, Lucarelli G, Bruzzese D, Perdonà S, Mazzarella C, Perruolo G ... Anticancer Res., 2015 | 57 | 2015 |
Oleic acid promotes prostate cancer malignant phenotype via the G protein‐coupled receptor FFA1/GPR40 A Liotti, V Cosimato, P Mirra, G Calì, D Conza, A Secondo, G Luongo, ... Journal of cellular physiology 233 (9), 7367-7378, 2018 | 54 | 2018 |
Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of the literature F Crocetto, E di Zazzo, C Buonerba, A Aveta, SD Pandolfo, B Barone, ... Nutrients 13 (11), 3750, 2021 | 42 | 2021 |
uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors N Montuori, V Cosimato, L Rinaldi, VEA Rea, D Alfano, P Ragno Thrombosis and haemostasis 109 (02), 309-318, 2013 | 34 | 2013 |
Surface endoglin (CD105) expression on acute leukemia blast cells: an extensive flow cytometry study of 1002 patients V Cosimato, G Scalia, M Raia, L Gentile, V Cerbone, F Visconte, T Statuto, ... Leukemia & lymphoma 59 (9), 2242-2245, 2018 | 11 | 2018 |
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials M Ferro, G Di Lorenzo, O de Cobelli, D Bruzzese, P Pignataro, ... World Journal of Urology 37, 1049-1059, 2019 | 6 | 2019 |
Mean reticolocyte hemoglobin content index plays a key role to identify children who are carriers of β-thalassemia P Vicinanza, M Vicinanza, V Cosimato, D Terracciano, S Cancellario, ... Translational Medicine@ UniSa 17, 31, 2017 | 6 | 2017 |
Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer M Ferro, G Lucarelli, C Buonerba, D Terracciano, G Boccia, G Cerullo, ... Therapeutic Advances in Urology 13, 17562872211026404, 2021 | 5 | 2021 |
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy M Ferro, G Lucarelli, O de Cobelli, P Dolce, D Terracciano, G Musi, ... Future Oncology 17 (30), 3987-3994, 2021 | 4 | 2021 |
Immune checkpoint inhibitors in penile cancer C Buonerba, L Scafuri, F Costabile, B D’Ambrosio, S Gatani, P Verolino, ... Future Science OA 7 (7), FSO714, 2021 | 2 | 2021 |
OLEATE INCREASES SIRT-1 EXPRESSION IN PROSTATE CANCER CELLS M Ferro, V Cosimato, E Giorgio, G Perruolo, A Marino, C Mazzarella, ... ANTICANCER RESEARCH 34 (5), 2615-2616, 2014 | | 2014 |
METABOLIC MECHANISM REGULATING PROSTATE CANCER CELL MALIGNANT PHENOTYPE M Ferro, DV Matei, D Bottero, G Musi, A Cioffi, V Altieri, P Formisano, ... ANTICANCER RESEARCH 34 (5), 2604-2605, 2014 | | 2014 |
AKT ACTIVATION IS INVOLVED IN OLEATE-INDUCED DOCETAXEL RESISTANCE IN ANDROGEN-INDEPENDENT PROSTATE CANCER CELLS M Ferro, V Cosimato, A Marino, E Giorgio, C Armellino, S Melegari, ... ANTICANCER RESEARCH 34 (5), 2615-2615, 2014 | | 2014 |
INCREASING PROSTATE CANCER DETECTION BY A MODEL INCLUDING PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3) SP Matteo Ferro, Ada Marino, Liberato Gargiulo ANTICANCER RESEARCH 33 (5), 2275-2276, 2013 | | 2013 |
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors N Montuori, C Di Giovanni, VAE Rea, D Alfano, A Gorrasi, V Cosimato, ... Molecular and Cellular Biology of Plasminogen Activation, 72-72, 2011 | | 2011 |